About Transcenta Therapeutics Transcenta (HKEX: 06628) is a global clinical stage biopharmaceutical company with fully integrated capabilities in antibody-based biotherapeutics discovery, research, ...

Digital GMP expectations are increasing, driven by Annex 11 and Annex 22, necessitating robust lifecycle management, data ...

In an era defined by rapid technological disruption and shifting economic paradigms, the traditional structures of Nigerian ...

The new Emerson DeltaV PKM library reportedly cuts months from drug development by providing pre-built specification elements ...

Hungry individuals don't put much thought into the packaging of their food. When people grab a snack, they generally rip into ...

Akari Therapeutics (AKTX) announced the initiation of GMP manufacturing activities to support the development of AKTX-101, the Company’s lead ADC ...

Pluri (PLUR) announced expansion of its manufacturing agreement signed in 2024 with Remedy Cell. Under the ongoing collaboration Remedy Cell’s ...

Under the ongoing collaboration Remedy Cell’s personnel, along with Pluri’s Contract Development and Manufacturing Organization (“CDMO”) division (PluriCDMO™), have successfully completed the full ...

ShineOn’s proprietary product, SOB100, a HLA-G targeted exosome drug delivery carrier, has passed the U.S. FDA IND review and ongoing Phase I study, making it as a first-in-class–potential HLA-G ...

Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs present new challenges.

ALIGNING THE CHILDHOOD VACCINE SCHEDULE WITH INTERNATIONAL BEST PRACTICES: Today, President Donald J. Trump signed a Presidential Memorandum to begin the process to align U.S. core childhood vaccine ...

Divya Narain consults for Friends of the Earth, US and has received research funding from the Tiny Beam Fund. In sub-Saharan Africa, pastoral livestock farming – where cattle, goats and sheep roam ...